《精编》我国中药市场现状及其相关情况分析

上传人:tang****xu3 文档编号:133259843 上传时间:2020-05-25 格式:DOC 页数:24 大小:225.92KB
返回 下载 相关 举报
《精编》我国中药市场现状及其相关情况分析_第1页
第1页 / 共24页
《精编》我国中药市场现状及其相关情况分析_第2页
第2页 / 共24页
《精编》我国中药市场现状及其相关情况分析_第3页
第3页 / 共24页
《精编》我国中药市场现状及其相关情况分析_第4页
第4页 / 共24页
《精编》我国中药市场现状及其相关情况分析_第5页
第5页 / 共24页
点击查看更多>>
资源描述

《《精编》我国中药市场现状及其相关情况分析》由会员分享,可在线阅读,更多相关《《精编》我国中药市场现状及其相关情况分析(24页珍藏版)》请在金锄头文库上搜索。

1、国内外中药市场分析摘要Excerpt ofAnalysis of TCM Market in China and the World2011年1月25日January 25, 2011目录一、中药产品简介I. Brief introduction of TCM (traditional Chinese medicine) products中药是指在中医药理论指导下用以防治疾病的药物,其来源包括植物药、动物药和矿物药。植物药占绝大多数。中药产品是指上述药物的制成品。Traditional Chinese Medicine (TCM) refers to the drugs used to pre

2、vent disease under the guidance of TCM theory, whose sources include botanical drugs, animal drugs and mineral drugs. Botanical drugs account for the largest proportion. TCM products refer to patterned Chinese herbal products manufactured with above medicine.中药与西方植物药的比较Comparison between TCM and Wes

3、tern botanical drugs项目Project中药TCM西方植物药Western botanical drugs 理论Theory有系统理论,强调辨证施治,以性味归经理论原理指导临床用药With systematic theory, emphasizing on treatment based on different syndromes , guiding clinical medication with the theory of four properties, five tastes and channel distribution.虽有一定的用药经验,但未形成较系统的理论

4、Having some clinical applications, but no systematic theory was formed.来源Sources植物、动物和矿物Plants, animals and minerals.以植物为主Most are plants.方剂Prescription强调配伍组方用药,即君臣佐使,七情和合,充分发挥药物之间的相互作用,多为复方用药Emphasizing on composition and seven conditions in making up prescription; fully leverage the interaction be

5、tween drugs, and most drugs are compound medicine.大多为单方,少数为组合用药Most are single-ingredient medicine; compound medicine is rare.炮制加工Processing有系统和经过数千年实践的炮制经验和工艺Having systematic processing techniques based on thousand-year- practicing.无传统,无专门的炮制要求No traditional or special processing techniques.临床使用情况

6、Clinical use1.丰富的实践,浩瀚文献,数千年实践考验;2.对慢性病、疑难杂症、老年病尤为擅长;3.对非器质性的功能性疾病有明显的疗效1. Having extensive practice, vast literature and improved by thousands of years practice; 2. Especially effective for chronic diseases, complicated diseases and senile diseases; 3. Having evident efficacy for functional disease

7、s with non-organic damage.1.最长仅几百年历史;2.主要用于轻症,预防感冒、失眠、消化不良、食欲不佳、紧张,列入OTC药范围,被认为只是辅助作用1. Only with a history of a few hundred years for the most; 2. Mainly used for mild case, preventing cold, insomnia, indigestion, poor appetite and nervousness, which are included in the scope of OTC drugs and only

8、have an adjunctive therapy role.临床前期慢毒、急毒及三致试验Pre-clinical chronic and acute toxicity test; carcinogenicity, teratogenicity and mutagenicity test.常缺乏GLP实验室水准的实验数据 Lack the experimental data at the level of GLP laboratory.部分具有Some of them have the experimental data at the level of GLP laboratory.临床试验

9、Clinical trials常缺乏双盲法等临床数据Often lack of clinical data of double blind and other studies. 现代研究强调用双盲法Double blind method is emphasized in modern studies.发现新药Development of new drugs因为有规律及丰富经验积累,是开发新药的重要途径Because of its regularity and rich experience in practice, it is an important way to develop new d

10、rugs. 有生命力,但无法与中药相比Vigorous; but inferior to TCM二、中国医药市场II. Chinese pharmaceutical market医药工业是国民经济的重要组成部分,2003年全国医药产品销售收入完成2961亿元,其中化学药品原料药产量为80.35万吨,中成药产量为60.29万吨。据国家食品药品监督管理局(SFDA)南方医药经济研究所统计,2008年全年医药工业生产总值(现价)基本达到7080亿元,同比增长约18%。Pharmaceutical industry sector is an important part of the economy

11、in China. Sales of pharmaceutical products nationwide were RMB 296.1 billion in 2003, of which bulk pharmaceutical chemicals were 803,500 tons and TCM drugs were 602,900 tons. According to the data of Southern Medical Economic Research Institute of the State Food and Drug Administration (SFDA), the

12、total output value (current prices) of pharmaceutical sector basically reached RMB 708 billion in 2008, up by about 18% year on year.三、中国中药市场现状及其相关情况分析III. Status quo of TCM Market in China1. 中国中药市场发展现状1. Status quo of TCM Market in China中药行业是医药行业的子行业,由中药材生产、中药工业(含中药饮片加工、中成药生产、中药机械制造)和中药商业组成。经过长期发展,

13、中国已形成了以中药材生产为基础,中药工业为主体,中药商业为纽带的中药生产流通体系。到2001年年底,全国拥有中成药企业1208家,能生产35大类、43种剂型、5000多种中成药,另有生产中药的西药企业近1000家,中药饮片和保健品企业近3000家。根据国家经贸委(现发改委)经济运行局统计数据,2002年中国中药企业(包括中成药工业企业和中药饮片工业企业)纳入统计口径的总计1150家。中药行业的工业总产值及中药行业年销售收入呈逐年上升趋势。TCM is an industry within the pharmaceutical industry sector, consisting of raw

14、 TCM herbs production, TCM manufacturing (including processing of prepared TCM herbs, production of Chinese patent drugs and manufacturing of TCM equipment) and TCM business. After a long-term development, a production and distribution system has formed in China, with Raw TCM herbs manufacturing as

15、the basis, TCM manufacturing as the main body and TCM business circulation as a link. By the end of 2001, there were 1,208 Chinese patent drug enterprises, which could produce Chinese patent drugs in 35 categories, 43 types of dosage forms and 5,000 types. In addition, there were nearly 1,000 Western medicine enterprises producing TCM and 3,000 enterprises producing prepared TCM herbs and health-care products. According to the statistic data of Bureau of Economic Operation of State Economic and Trade Commission (now National Development and Reform Commission), a total of 1,150 TC

展开阅读全文
相关资源
相关搜索

当前位置:首页 > 行业资料 > 其它行业文档

电脑版 |金锄头文库版权所有
经营许可证:蜀ICP备13022795号 | 川公网安备 51140202000112号